325 related articles for article (PubMed ID: 6934851)
21. [Comparison of 2 regimens of polychemotherapy in refractory acute leukemia or in relapse].
Borbolla-Escoboza JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba-Christy E; Anaya-Cuéllar I
Rev Invest Clin; 1998; 50(4):307-10. PubMed ID: 9830318
[TBL] [Abstract][Full Text] [Related]
22. Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B Study.
Terebelo HR; Anderson K; Wiernik PH; Cuttner J; Cooper RM; Faso L; Berenberg JL
Am J Clin Oncol; 1986 Oct; 9(5):411-5. PubMed ID: 3465228
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
[TBL] [Abstract][Full Text] [Related]
24. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen.
Bassan R; Battista R; Viero P; Pogliani E; Rossi G; Lambertenghi-Deliliers G; Rambaldi A; D'Emilio A; Buelli M; Borleri G
Semin Oncol; 1993 Dec; 20(6 Suppl 8):39-46. PubMed ID: 7507263
[TBL] [Abstract][Full Text] [Related]
25. Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study.
Tsukune Y; Isobe Y; Yasuda H; Shimizu S; Katsuoka Y; Hosone M; Oshimi K; Komatsu N; Sugimoto K
Eur J Haematol; 2010 Apr; 84(4):310-5. PubMed ID: 20015242
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
27. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
28. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia.
Tribalto M; Amadori S; Avvisati G; Del Bianco P; Franchi A; Gallerano T; Papa G; Mandelli F
Haematologica; 1985; 70(4):319-23. PubMed ID: 3935530
[No Abstract] [Full Text] [Related]
30. [Attempts at treatment of acute leukemia with L-asparaginase].
Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
[No Abstract] [Full Text] [Related]
31. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M
J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600
[TBL] [Abstract][Full Text] [Related]
32. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
33. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
Miniero R; Pastore G; Saracco P; Messina M; Lange MM; Fiandino G; Iannacci L; Madon E
Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716
[TBL] [Abstract][Full Text] [Related]
34. Effective remission induction of refractory childhood acute nonlymphocytic leukemia by VP-16-213 plus azacitidine.
Look AT; Dahl GV; Kalwinsky D; Senzer N; Mason C; Rivera G
Cancer Treat Rep; 1981; 65(11-12):995-9. PubMed ID: 6170431
[TBL] [Abstract][Full Text] [Related]
35. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
[No Abstract] [Full Text] [Related]
36. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
[TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia.
Evans WE; Abromowitch M; Crom WR; Relling MV; Bowman WP; Pui CH; Ochs J; Dodge R
NCI Monogr; 1987; (5):81-5. PubMed ID: 3481040
[TBL] [Abstract][Full Text] [Related]
38. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
39. [L-Asparaginase in the treatment of acute leukemia].
Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
[No Abstract] [Full Text] [Related]
40. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]